logo
Plus   Neg
Share
Email

Lilly Plans To Invest $400 Mln In Manufacturing Facilities In Indianapolis

Eli Lilly and Co. (LLY) said Wednesday that it plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus in Indianapolis, and create about 100 new jobs at the company.

"These investments support our manufacturing capabilities in Indianapolis, including additional capacity and technology upgrades to our active ingredient, syringe filling, device assembly and packaging operations," said Myles O'Neill, senior vice president and president of Manufacturing Operations.

Lilly noted that it has invested over $5 billion in the United States since 2012, with the majority of the investment in its Indiana facilities and nearly $2 billion in manufacturing of diabetes medicines.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry. Graco Inc. (GGG) shares were climbing more than 7 percent in morning trade. Monday after market close, the company had reported a surge in the fourth-quarter earnings to $84.8 million from $73.7 million in the prior year. Earnings per share surpassed analysts' estimates. Sales were up 1 percent to $412.3... Strategy of getting multiple indication approvals for the same drug seems to be paying off for AstraZeneca PLC (AZN), in terms of higher likelihood of approval and improved sales. Besides, the company is realizing value from non-core, mature brands to invest in new drugs, which also seems to be working in its favor.
Follow RTT
>